4Fujita J, Dohmoto K, Hojo S, et al. The pointutation in the promoter region and the single nucleotide polymorphis minexonl of the cytokeratin genein human lung cancer cell lines. Lung Cancer,2001,34( 3 ) : 387.
5Gu CD, Osaki T, Oyama T, et al. Detection of micrometastatic tumor cell sinpolymphnodes of patients with complete lyresected non small cell lung cancer: impact on recurrence and survival. Ann Surg,2002, 235(1) :133
6Gessner G,Kuhn H,Toepfer K,etal. Detection of P53 mutations in exhaled breath condensate of non-small cell lung cancer patients. Lung Cancer,2004,43 ( 2 ) :215 - 222.
8Pino I, Pio R, Toledo G, et al. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) familyin lung cancer. Lung Cancer,2003,41 (2) :131 - 143.
9Shibuya K, Fujisawa T, Hoshino H, etal. Increased telomerase activity and hTERT mRNA expression during multistage carcinogenesis of squamous cell of the lung. Cancer,2001,92(4) :849 -855.
2Nakachi K, Hayashi S, Kawajiri K, et al.Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation. Carcinogenesis, 1995, 16 (9) : 2209-2213.
3Le Marchand L, Sivaraman L, Pierce L, et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res, 1998, 58 (21) :4858-4863.
4Persson I, Johansson I, Bergling H, et al.Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett,1993,319(3) : 207-211.
6Wikman H, Thiel S, Jager B, et al. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.Pharmacogenetics, 2001,11 (2) : 157-168.
7Tockman MS. Clinical detection of lung cancer progression markers. J Cell Biochem Suppl,1996,25: 177-184.
8Ahrendt SA , Chow JT , Xu LH , et al .Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst,1999,91(4) : 332-339.
9Tseng JE, Rodriguez M, Ro J, et al. Gender differences in p53 mutational status in small cell lung cancer. Cancer Res, 1999,59(22) : 5666-5670.
10Chen JT, Ho WL, Cheng YW, et al. Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma. Anticancer Res, 2000,20 (4) :2687-2690.
